Home / News / Life Science M&A Deals on the Rise in Slovenia

Life Science M&A Deals on the Rise in Slovenia

Published on ceelegalmatters.com

Foreign investors of all types were increasingly interested in Life Science (LS) companies even before COVID-19 emerged. It is no wonder that Slovenian LS companies are of particular appeal, since this highly innovative community significantly contributed to Slovenia being ranked 21st in this year’s Bloomberg Innovation Index. Some say COVID-19 catalyzed the new deals this year, but they were more likely fostered by the new investment opportunities that keep popping up with each innovative solution offered by the relatively small (and relatively inexpensive) companies in Slovenia. The race to acquire these innovative scale-ups and start-ups has become increasingly competitive.

Related people

Saša Sodja
Saša Sodja
Partner
Ljubljana